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Review
During gestation, potentially harmful 
 pollu tants circulating in the blood of preg-
nant women can reach the fetus, although 
possible mother-to-child transmission of 
these toxic substances is modulated by the 
placenta. Some authors (Iyengar and Rapp 
2001a; Subramanian and Iyengar 1997) have 
proposed the use of placental tissue as a non-
invasive exposure biomarker for different 
organic and inorganic pollutants. This tissue, 
usually discarded after birth, is easy to obtain 
and may furnish information on the exposure 
of both mother and fetus.
Among the contaminants eligible for 
being studied in this tissue, some heavy met-
als are of special interest when it comes to 
gestation. Exposure to either mercury (Hg) or 
lead (Pb) has well known deleterious effects 
on the intellectual development of children 
(Jakubowski 2006), and embryotoxic and 
feto toxic effects associated with exposure 
to cadmium (Cd) have also been described 
(Hazelhoff et al. 1987). 
We reviewed published research on total 
Hg, Cd, and Pb levels in human placenta, both 
in pregnant women from the general popu-
lation and in those with specific exposures, 
as well as the factors related to such levels, in 
order to summarize available information for 
researchers considering the use of placenta to 
bio monitor exposure to these metals.
Methods
Search strategy. The systematic search and 
review processes were conducted in accor-
dance with the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses 
(PRISMA) Statement criteria (Liberati et al. 
2009). We searched PubMed/MEDLINE 
(http://www.ncbi.nlm.nih.gov/pubmed/), 
EMBASE (http://www.embase.com/home), 
LILACS (http://lilacs.bvsalud.org/en/), OSH 
(http://www.oshupdate.com/), and Web 
of Science (http://www.accesowok.fecyt.es) 
databases using the following MeSH terms: 
“placenta” successively combined with “pollu-
tants,” “cadmium,” “mercury,” “lead,” and 
“bio monitoring.” This was supplemented by 
manual searches based on the references cited 
in the papers initially identified. We consid-
ered only studies on human subjects published 
in English or Spanish from January 1976 
through November 2011. This strategy yielded 
1,629 references [see Supplemental Material, 
Figure S1 (http://dx.doi.org/10.1289/
ehp.1204952)]. From these, we selected the 
studies that furnished original quantitative 
data on total Hg, Cd, or Pb levels measured in 
human placental tissue samples.
Data extraction. Using a standard, pur-
pose-designed form, we extracted the follow-
ing data from each paper: a) study design, 
date and place, participants, sampling method 
and size, inclusion and exclusion criteria, and 
request for informed consent; b) protocol for 
collection, storage, processing, and analysis of 
biologic specimens; and, c) results, including 
metal levels and related factors. Where con-
centrations were expressed in dry weight (dw), 
we calculated wet weight (ww) by dividing the 
figure by the dw/ww ratio, if provided, or by 
a value of 6, if the dw/ww ratio was not pro-
vided (Iyengar and Rapp 2001b); where the 
type of weight was unspecified, we allocated 
ww or dw in light of the range of values used. 
We report the arithmetic and/or geometric 
mean, and we include SD, median, and range 
where provided. In view of the hetero geneous 
results displayed by the original studies, we felt 
that quantitative pooling was inappropriate.
Results
Description of the Studies
We included a total of 79 reports on 73 dif-
ferent studies. Twenty-four studies reported 
placental Hg levels, 46 reported Cd lev-
els, and 46 reported Pb levels; papers fre-
quently provided results on more than one 
trace metal. The main charac teristics of 
each study are described in Supplemental 
Mate r i a l ,  Tab l e  S1  (h t tp : / /dx .do i .
org/10.1289/ehp.1204952), and metal levels 
are summarized in Supplemental Material, 
Tables S2–S4. The full text was unavailable 
for 8 papers; for those papers, data shown in 
the summary tables came from the abstracts 
or from reviews of those studies. The number 
of papers increased over time, reaching a peak 
in the past decade because of studies address-
ing placental Cd and Pb (see Supplemental 
Material, Figure S2). Whereas older studies 
were mainly undertaken in the United States 
and Western Europe, studies targeting popu-
lations in India, China, Eastern Europe, and 
South America began to be published in the 
1990s, and accounted for the bulk of pub-
lished works from 2000 and later.
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Background: Placental tissue may furnish information on the exposure of both mother and fetus. 
Mercury (Hg), cadmium (Cd), and lead (Pb) are toxicants of interest in pregnancy because they are 
associated with alterations in child development. 
oBjectives: The aim of this study was to summarize the available information regarding total Hg, 
Cd, and Pb levels in human placenta and possible related factors.
Methods: We performed a systematic search of PubMed/MEDLINE, EMBASE, Lilacs, OSH, and 
Web of Science for original papers on total Hg, Cd, or Pb levels in human placenta that were pub­
lished in English or Spanish (1976–2011). Data on study design, population charac teristics, collec­
tion and analysis of placenta specimens, and main results were extracted using a standardized form.
results: We found a total of 79 papers (73 different studies). Hg, Cd, and Pb levels were reported 
in 24, 46, and 46 studies, respectively. Most studies included small convenience samples of healthy 
pregnant women. Studies were hetero geneous regarding populations selected, processing of speci­
mens, and presentation of results. Hg concentrations > 50 ng/g were found in China (Shanghai), 
Japan, and the Faroe Islands. Cd levels ranged from 1.2 ng/g to 53 ng/g and were highest in the 
United States, Japan, and Eastern Europe. Pb showed the greatest variability, with levels ranging 
from 1.18 ng/g in China (Shanghai) to 500 ng/g in a polluted area of Poland.
conclusion: The use of the placenta as a biomarker to assess heavy metals exposure is not properly 
developed because of hetero geneity among the studies. International standardized protocols 
are needed to enhance comparability and increase the usefulness of this promising tissue in 
biomonitoring studies.
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Design: designated objectives and study 
subjects. Most of the papers reviewed were 
cross-sectional studies with three distinct types 
of objective, often combined in the same 
report. Most studies adopted a bio monitoring 
standpoint. Among these, some included vari-
ability by region of origin, rurality, or lifestyle 
aspects, with smoking being the determinant 
most frequently studied, especially in stud-
ies measuring Cd. Another objective was 
the acquisition of in-depth knowledge on 
the metabolism of metals and their passage 
through the placenta, assessing the placenta’s 
possible barrier effect by examining the link 
between placental levels and other related bio-
markers. Indeed, 25 studies collected other 
complementary biologic specimens, such as 
maternal and umbilical cord blood, cord tissue, 
maternal milk, maternal or newborn hair and 
urine, or meconium. Finally, some researchers 
assessed the association between metal levels 
and dis orders in the progress of pregnancy or 
newborn develop ment, including pre mature 
membrane rupture or pre term births (Ahamed 
et al. 2009; Baghurst et al. 1991; Falcón et al. 
2003a); gestational age and anthropomet-
ric data (Ahamed et al. 2009; Baghurst et al. 
1991; Falcón et al. 2003a, 2003b; Frery et al. 
1993; Guo et al. 2010; Kantola et al. 2000; 
Khera et al. 1980; Kippler et al. 2010; Klapec 
et al. 2008; Llanos and Ronco 2009; Loiacono 
et al. 1992; Osada et al. 2002; Pitkin et al. 
1976; Roels et al. 1978; Ronco et al. 2005a; 
Saxena et al. 1994; Stasenko et al. 2010; 
Tekin et al. 2011a, 2011b; Wibberley et al. 
1977; Yang et al. 1997; Zhang et al. 2004); 
oligo hydramnios (Terrones-Saldivar et al. 
2008); intrauterine growth restriction (IUGR) 
(Klapec et al. 2008; Llanos and Ronco 2009; 
Osada et al. 2002); Apgar score at birth 
(Zhang et al. 2004); and fetal mal formations 
or stillbirths (Baghurst et al. 1991; Khera et al. 
1980; Saxena et al. 1994; Scaal et al. 1998; 
Wibberley et al. 1977).
Most studies included small groups of 
women, and only 19 included > 100 partici-
pants. Just 2 papers provided participation rates 
(Al Saleh et al. 2011; Lagerkvist et al. 1996), 
which was > 90% in both cases, and another 
study specified the dropout rate after recruit-
ment (Gundacker et al. 2010). The inclusion 
criteria were frequently poorly described, and 
in some cases were limited to a mere refer-
ence to geographic origin (Baranowska 1995; 
Karp and Robertson 1977; Schramel et al. 
1988). The most common practice of the 
reviewed studies was to include non randomly 
selected convenience samples of healthy preg-
nant women without known risk exposures 
and who had full-term births and normal 
neonates. However, some studies included 
pregnant women with a higher probability 
of environ mental exposure to heavy metals, 
whether by occupational exposure (Berlin et al. 
1992; Khera et al. 1980; Mayer-Popken et al. 
1986; Yang et al. 1997) or high environmental 
exposure (Baghurst et al. 1991; Diaz-Barriga 
et al. 1995; Fahim et al. 1976; Guo et al. 2010; 
Lagerkvist et al. 1996; Loiacono et al. 1992). 
Other studies targeted women who experi-
enced problems with fetal development or 
pregnancy (Baghurst et al. 1991; Khera et al. 
1980; Saxena et al. 1994; Scaal et al. 1998; 
Terrones-Saldivar et al. 2008; Wibberley et al. 
1977). Some studies used type of delivery as an 
inclusion criterion, although only 15 reports 
provided this information. Of these, 9 covered 
only non complicated vaginal births (Ahamed 
et al. 2009; Capelli et al. 1986; Frery et al. 
1993; Kantola et al. 2000; Needham et al. 
2011; Pitkin et al. 1976; Stasenko et al. 2010; 
Tsuchiya et al. 1984; Zagrodzki et al. 2003), 
4 combined vaginal and cesarean (C)-section 
births (Bush et al. 2000; Sorkun et al. 2007; 
Tekin et al. 2011a, 2011b; Terrones-Saldivar 
et al. 2008), and 1 exclusively included placen-
tas from C-section births (Fagher et al. 1993). 
Regarding ethical considerations, 28 papers 
expressly referred to informed consent as 
a pre requisite for study participation and 
14—mostly recent—mentioned the approval 
of an ethics committee.
Analytical methodology: collection, pro-
cessing, and analysis of biologic specimens. 
Pretreatment of the placenta, which was not 
always specified, varied widely. In general, 
the organ was frozen and stored, either whole, 
processed, or in the form of the specimen 
collected. Usually, the placenta had an initial 
washing to remove blood or clots; in some 
studies the decidua basalis, chorionic plate, 
or connective tissue and blood vessels were 
eliminated, whereas in others only the cotyle-
don was analyzed. In most instances, a single 
spot specimen of placenta weighing only a few 
grams was obtained, without specifying the 
placental area sampled. Other researchers col-
lected several speci mens from different areas, 
typically to analyze them jointly and some-
times to carry out inter comparisons among 
the individual results (Kippler et al. 2010; 
Lagerkvist et al. 1996; Piasek et al. 2001). 
Finally, in other studies the complete placenta 
or one of its halves was homogenized, and 
part of this preparation was analyzed.
In general, different types of spectrometry 
were used, except in one case in which both 
Cd and Pb were determined using a hanging 
Hg drop electrode (Kutlu et al. 2006) and in 
five studies in which Hg was measured using 
an unspecified Hg analyzer (Hsu et al. 2007) 
or instrumental neutron activation analysis 
(Grant et al. 2010; Horvat et al. 1988; Llanos 
and Ronco 2009; Ward et al. 1987). These 
details were not always provided (Karp and 
Robertson 1977).
Information on laboratory quality con-
trols differed between the earliest and the 
more recent papers: Before the year 2000, only 
11 studies (26.8%) specified having inter-
nal quality controls and 6 studies (14.6%) 
mentioned external controls. In contrast, 
all studies published after 2000 except 1 
(Terrones-Saldivar et al. 2008) reported the 
use of standardized quality control proce-
dures that generally comprised evaluation of 
accuracy and precision by analysis of certi-
fied reference material, and 2 studies included 
additional inter laboratory comparisons (Singh 
et al. 2010; Zagrodzki et al. 2003). Only half 
of the studies specified the limit of detection 
(LOD), merely stating the value or including 
the procedure used to treat values below it.
In the reviewed studies, there was no uni-
form pattern for reporting results: 28 studies 
described levels in terms of wet weight, 26 in 
terms of dry weight, and the remainder did 
not specify this aspect. Four papers used their 
own data to calculate the dw/ww ratio, which 
was 6.32 (Capelli et al. 1986), 6.2 (Schramel 
et al. 1988), 6.9 ± 1.3 (mean ± SD; Osada 
et al. 2002) and 5.7 (range, 4.8–7.7) (Kippler 
et al. 2010), respectively, whereas 2 papers 
used a fixed ratio of 6.0 (Baghurst et al. 1991; 
Frery et al. 1993). As units of measurement, 
most authors used nanograms or micrograms 
per unit weight, although nanomoles and 
parts per billion were also employed; some 
reports seemed to contain errors in the units 
(Kantola et al. 2000; Li et al. 2000; Loiacono 
et al. 1992; Singh et al. 2010).
Statistical analysis and reporting of results. 
Most of the studies (84.7%) provided arith-
metic means, usually accompanied by SDs. 
Other widely used indicators were median 
(29 studies) and range (28 studies); geometric 
mean was reported in 7 papers. With one 
exception (Al Saleh et al. 2011), authors did 
not include confidence intervals nor did they 
mention the evaluation of outliers or the use 
of robust measures of central trend. 
Studies assessing associations with risk 
factors generally furnished correlation coef-
ficients drawn from uni variate analyses, or 
differences in means derived from stratified 
analyses; few reports carried out multi variate 
analyses (Al Saleh et al. 2011; Falcón et al. 
2002, 2003a, 2003b; Gundacker et al. 2010; 
Kantola et al. 2000; Kippler et al. 2010; 
Klapec et al. 2008; Lagerkvist et al. 1996; 
Loiacono et al. 1992; Osada et al. 2002; 
Zhang et al. 2004).
Placental Trace-Metal Levels
The individual results yielded by studies on 
Hg, Cd, and Pb that we reviewed are presented 
in Supplemental Material, Tables S2, S3, and 
S4, respectively (http://dx.doi.org/10.1289/
ehp.1204952).
Total Hg. Twenty-four studies reported 
total Hg levels, although only 4 included 
> 100 women [see Supplemental Material, 
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Table S2 (http://dx.doi.org/10.1289/
ehp.1204952)]. The arithmetic mean Hg levels 
reported in those studies having this informa-
tion are presented in Figure 1. Hg concentra-
tions varied widely; the highest were found in 
China (Shanghai) and Japan (Suzuki et al. 
1984; Tsuchiya et al. 1984; Yang et al. 1997), 
where the mean exceeded 50 ng/g, and in the 
Faroe Islands, with a median of approximately 
90 ng/g (Needham et al. 2011). In contrast, 
in Germany (Schramel et al. 1988) and the 
Ukraine (Zadorozhnaja et al. 2000), most sam-
ples were < LOD. Three studies also provided 
the proportion of organic to inorganic Hg 
(Capelli et al. 1986; Soria et al. 1992; Suzuki 
et al. 1984).
Relationship between Hg in the placenta 
and other specimens. Studies that compared 
Hg concentration in the placenta with lev-
els in maternal or cord blood yielded con-
flicting results. In general, higher Hg levels 
were observed in the placenta (Galster 1976; 
Gundacker et al. 2010; Hsu et al. 2007; Pitkin 
et al. 1976; Tsuchiya et al. 1984; Yang et al. 
1997), suggesting an accumulation of this 
metal during pregnancy. Nevertheless, other 
authors reported placental levels that were 
lower than blood levels (Hubermont et al. 
1978; Roels et al. 1978; Truska et al. 1989).
Almost all studies reported a positive cor-
relation between placental Hg and venous 
(Al Saleh et al. 2011; Galster 1976; Marques 
et al. 2007; Needham et al. 2011; Tsuchiya 
et al. 1984) or arterial cord blood (Soria et al. 
1992), umbilical tissue (Needham et al. 2011), 
or maternal and neonate hair Hg (Marques 
et al. 2007). For maternal blood, however, 
results were inconsistent (Al Saleh et al. 2011; 
Roels et al. 1978).
Association between Hg, maternal charac­
teristics, and exposure to possible risk factors. 
In general, no association was found with 
maternal age or parity (Pitkin et al. 1976; Roels 
et al. 1978), although Al Saleh et al. (2011) 
described a signifi cant association with body 
mass index (BMI) after controlling for possible 
confounders. 
Fish intake, the most common source of 
population exposure to Hg, was the risk factor 
that was most widely studied for Hg levels. 
The highest levels were found in regions with 
high fish consumption, such as Japan and the 
Faroe Islands (Needham et al. 2011; Tsuchiya 
et al. 1984). In a small study on Eskimo 
women, Galster (1976) also observed a posi-
tive association between diets very rich in fish 
or whale meat and placental Hg. However, 
in two studies (Hsu et al. 2007; Marques 
et al. 2007), differences in intake during preg-
nancy were not associated with Hg levels in 
populations whose diet included lower fish 
consumption, although an association with 
consumption prior to pregnancy was suggested 
(Hsu et al. 2007). 
Few studies have examined the role of 
non dietary exposures to Hg. Some researchers 
have reported an absence of association with 
drinking habits (Roels et al. 1978), dental fill-
ings (Hsu et al. 2007), or tobacco abuse (Roels 
et al. 1978). Some studies reported contra-
dictory results related to residence in areas 
with industrial exposure (Karp and Robertson 
1977; Zadorozhnaja et al. 2000), whereas oth-
ers found no differences between women living 
in rural and urban settings (Roels et al. 1978; 
Truska et al. 1989). Data on occupational 
exposures were equally sparse: One small study 
of Chinese women exposed to Hg at a lamp 
factory reported elevated placental levels (Yang 
et al. 1997), yet we found no studies that had 
measured placental Hg levels among other 
occupationally exposed women, such as den-
tists or chloralkali plant workers.
Possible effects of Hg on the placenta 
or pregnancy. Karp and Robertson (1977) 
described a possible inhibitory effect of Hg 
on some placental enzymes implicated in 
the metabolism of carbohydrates and ste-
roids; however, no studies reported an 
association between total placental Hg and 
the anthropometric variables of neonates 
(Gundacker et al. 2010; Pitkin et al. 1976; 
Roels et al. 1978) or gestational age (Roels 
et al. 1978). A similar result was found 
in a study of fetuses with mal formations of 
unknown origin, in which Scaal et al. (1998) 
failed to observe evidence of Hg implication. 
Cd. We located 46 studies reporting placen-
tal levels of Cd; 17 of these had > 100 partici-
pants [see Supplemental Material, Table S3 
(http://dx.doi.org/10.1289/ehp.1204952)]. 
The average level of Cd varied widely 
(Figure 2)—ranging from 1.2 ng/g in Shanghai 
(Yang et al. 1997) to 53 ng/g in an urban area 
of the United States (Karp and Robertson 
1977)—and was particularly high, with values 
>20 ng/g, in some groups of pregnant women 
from Japan (Tsuchiya et al. 1984), Bangladesh 
(Kippler et al. 2010), Turkey (Kutlu et al. 
2006), and Eastern Europe (Fagher et al. 1993; 
Piasek et al. 2001; Reichrtova et al. 1998b; 
Stasenko et al. 2010).
Comparative analysis of Cd in pla­
centa and other specimens. Cd concentra-
tions in the placenta were much higher than 
those found in maternal and cord blood in 
Figure 1. Total Hg levels [arithmetic mean (ng/g ww)] in human placenta (1976–2011).
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all studies (Hubermont et al. 1978; Korpela 
et al. 1986; Kuhnert et al. 1982; Lagerkvist 
et al. 1996; Needham et al. 2011; Roels 
et al. 1978; Tsuchiya et al. 1984) except one 
(Truska et al. 1989). Placental Cd concentra-
tions were 10 times higher than that detected 
in maternal blood in one study (Roels et al. 
1978) and up to 100 times higher than that of 
cord blood in another (Needham et al. 2011). 
These data, along with the difference in pla-
cental Cd levels between the first trimester and 
at term (Kantola et al. 2000), indicate that Cd 
accumulates in the placenta during gestation 
and support the view that this organ is an effi-
cient (Baranowska 1995; Kuhnert et al. 1982; 
Roels et al. 1978; Schramel et al. 1988) or 
partially efficient barrier (Korpela et al. 1986; 
Needham et al. 2011) against this metal.
The Cd concentration in placenta was 
reported to be positively correlated with 
maternal blood Cd (Al Saleh et al. 2011; 
Lagerkvist et al. 1996; Odland et al. 2001; 
Roels et al. 1978; Schramel et al. 1988; Zhang 
et al. 2004)—both in plasma and in erythro-
cytes (Truska et al. 1989)—and with maternal 
urinary Cd (Kippler et al. 2010). The relation-
ship between placental and cord blood levels 
was somewhat less clear; although some stud-
ies found a correlation between them (Kippler 
et al. 2010; Needham et al. 2011; Tsuchiya 
et al. 1984; Zhang et al. 2004), others failed 
to do so (Al Saleh et al. 2011; Kuhnert et al. 
1982; Schramel et al. 1988). No association 
with Cd levels in breast milk was observed 
(Schramel et al. 1988), although few studies 
assessed this association.
Effects of collection, processing, and preser­
va tion of specimens. Pretreatment of placentas 
may be associated with higher levels of Cd 
in the specimen (Lagerkvist et al. 1996). In 
terms of the metal’s distribution in this organ, 
available data were contradictory: Some stud-
ies suggested that Cd was uniformly distrib-
uted throughout the placenta (Lagerkvist 
et al. 1996; Piasek et al. 2001), and others 
described differences between samples from 
the central and peripheral areas, without any 
clear gradient (Kippler et al. 2010). In pla-
centas from smokers, the Cd concentration 
seemed to be higher on the maternal side 
(Zhang et al. 2004). Higher levels of Cd were 
also observed in placentas with parenchymal 
calcifications, regardless of smoking habit, 
gestational age, or birth weight (Frery et al. 
1993). Milnerowicz (1993) reported that Cd 
levels were lower in fetal membranes. 
Association between maternal charac­
teristics and exposure to possible risk fac­
tors. The efficiency of the placenta as a 
barrier against the passage of Cd might be 
modulated by maternal poly morphisms in 
genes that code for metal-binding metallo-
thionein protein (Tekin et al. 2011a). Most 
studies found no association between pla-
cental Cd and parity or maternal age (Frery 
et al. 1993; Kantola et al. 2000; Klapec et al. 
2008; Loiacono et al. 1992; Roels et al. 1978; 
Terrones-Saldivar et al. 2008; Zadorozhnaja 
et al. 2000), although in some cases higher 
levels were detected in older mothers (Al Saleh 
et al. 2011; Fiala et al. 1998). In another 
U.S. study, a higher Cd concentration was 
observed in multi parous women, albeit exclu-
sively among smokers (Kuhnert et al. 1988). 
Among environmental exposures, smoking 
was the most widely studied factor. Published 
results clearly show that placental Cd levels in 
pregnant smokers are two to three times higher 
than those in pregnant non smokers (Bush et al. 
2000; Falcón et al. 2002, 2003b; Kantola et al. 
2000; Kuhnert et al. 1982; Kutlu et al. 2006; 
Lagerkvist et al. 1996; Moberg et al. 1992; 
Osman et al. 2000; Peereboom-Stegeman et al. 
1983; Pereg et al. 2001; Piasek et al. 2001; 
Roels et al. 1978; Ronco et al. 2005a, 2005b; 
Sorkun et al. 2007; Stasenko et al. 2010; 
Zhang et al. 2004). Several authors reported a 
positive correlation with the number of ciga-
rettes smoked daily (Bush et al. 2000; Falcón 
et al. 2002; Pereg et al. 2001); however, in 
a small study in the Netherlands, very heavy 
smokers (20 to 60 cigarettes/day) had lower 
levels than did intermediate smokers, sug-
gesting that a limited amount of Cd could be 
retained in the placenta (Peereboom-Stegeman 
et al. 1983). Furthermore, some studies 
found no evidence of any association between 
tobacco use and placental levels of Cd (Fagher 
et al. 1993; Frery et al. 1993; Odland et al. 
2001; Terrones-Saldivar et al. 2008). Only one 
Figure 2. Cd levels [arithmetic mean (ng/g ww)] in human placenta (1976–2011).
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Ronco et al. 2005a, Chile (Santiago)a
Kutlu et al. 2006, Turkeya
Sorkun et al. 2007, Turkeya
Klapec et al. 2008, Croatia
Terrones-Saldivar et al. 2008, Mexico
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Turkish study specifically reported Cd levels in 
women with passive tobacco exposure, and lev-
els were higher in those women compared with 
non smokers (Kutlu et al. 2006).
Important differences in placental Cd 
levels have been observed among pregnant 
non smokers by geographic region of origin 
(Kantola et al. 2000; Odland et al. 2004), 
indicating that these levels also reflect varia-
tions in other environ mental exposures. Several 
studies in residents in heavily polluted areas 
(Baranowska 1995; Zhang et al. 2004) or in the 
vicinity of metal installations, such as Pb smelt-
ers (Lagerkvist et al. 1996; Loiacono et al. 1992; 
Tabacova et al. 1994) or iron mines (Reichrtova 
et al. 1998b), generally regis tered high levels of 
Cd. Urban pollution also seemed to increase 
placental Cd (Baranowska 1995; Fagher et al. 
1993; Falcón et al. 2002; Reichrtova et al. 
1998b; Sorkun et al. 2007), even when smok-
ing was taken into account (Fagher et al. 1993; 
Guo et al. 2010; Roels et al. 1978; Sorkun et al. 
2007). In addition, a recent study in China 
suggested an association with indoor pollution 
(Guo et al. 2010). The few studies of occupa-
tional settings did not show a clear relation ship 
with Cd levels (Berlin et al. 1992; Roels et al. 
1978; Yang et al. 1997).
In terms of diet, one study reported lower 
placental Cd in women with high iron levels 
and low intake of cereals at the end of preg-
nancy (Moberg et al. 1992); no association was 
found with drinking habits (Roels et al. 1978).
Possible effects of Cd on the placenta or 
pregnancy. Because Cd accumulates in the 
placenta, higher levels would be expected in 
pregnancies of longer duration. Nonetheless, 
the studies we reviewed either found no asso-
ciation with gestational age (Frery et al. 1993; 
Loiacono et al. 1992; Roels et al. 1978) or 
reported an inverse relation ship (Falcón et al. 
2003b; Kippler et al. 2010). One small study 
observed higher Cd levels in pre term compared 
with full-term C-section placentas, although 
this difference was not statistically significant 
(Fagher et al. 1993). However, Zhang et al. 
(2004) found no association with pre maturity. 
In regard to other gestational problems, 
Terrones-Saldivar et al. (2008) observed higher 
levels in placentas from pregnancies with severe 
oligohydramnios. 
Research in this field has also assessed fetal 
develop ment and neo natal anthropometric 
data. Three small studies reported higher Cd 
in placentas from pregnancies with IUGR 
(Klapec et al. 2008; Llanos and Ronco 2009; 
Osada et al. 2002), although the differences 
were not always statistically significant (Osada 
et al. 2002). Other studies described a nega-
tive correlation with birth weight (Kippler 
et al. 2010; Ronco et al. 2005a; Stasenko 
et al. 2010), neonatal length (Stasenko et al. 
2010), and chest circumference (Kippler et al. 
2010). However, a few studies failed to find 
any association between Cd and infant mea-
sures (Guo et al. 2010; Tekin et al. 2011a) or 
neo natal Apgar score (Zhang et al. 2004). 
In terms of placental metabolism, the 
aspect most commonly described was the direct 
link between placental Cd and high levels of 
placental metallo thionein (Kippler et al. 2010; 
Ronco et al. 2006; Sorkun et al. 2007; Tekin 
et al. 2011a). Although this metallo protein 
is considered a protective cellular mechanism 
against Cd, its increase might, in turn, affect 
the passage of zinc into the fetus (Kippler et al. 
2010; Tekin et al. 2011a). Other reported 
effects of Cd include a decrease in placental 
synthesis of leptin (Stasenko et al. 2010) and 
increased activity of enzymes implicated in the 
metabo lism of carnitine and carbohydrates 
(Karp and Robertson 1977). Pereg et al. (2001) 
found no association between Cd and placental 
bulky DNA adduct levels. 
Pb. Placental Pb concentrations were 
reported in 46 studies, 15 of which had > 100 
participants [see Supplemental Material, 
Table S4 (http://dx.doi.org/10.1289/
ehp.1204952)]. Average Pb levels ranged from 
500 ng/g in women residing in Silesia, a heav-
ily polluted region of Poland (Baranowska 
1995), to 1.18 ng/g in Shanghai (China) (Li 
et al. 2000). Figure 3 presents the reported 
arithmetic means of placental Pb. Although 
concentrations > 100 ng/g were commonly 
observed in Western Europe and North 
America in the 1970s, since the 1980s Pb 
levels have remained < 50 ng/g. Some studies 
conducted during the last 20 years in Eastern 
Europe, South America, Asia, and North 
Figure 3. Pb levels [arithmetic mean (ng/g ww)] in human placenta (1976–2011). Studies undertaken in 
(A) Western Europe and North America and (B) Eastern Europe, Latin America, and Asia.
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Africa still reflect very high levels of placental 
Pb, particularly in India (Ahamed et al. 2009; 
Saxena et al. 1994; Singh et al. 2010).
Comparative analysis of Pb in the pla­
centa and other specimens. Placental Pb levels 
were usually lower than those found in mater-
nal (Baghurst et al. 1991; Baranowska 1995; 
Lagerkvist et al. 1996) or cord blood (Baghurst 
et al. 1991; Baranowska 1995; Hubermont 
et al. 1978; Korpela et al. 1986; Lagerkvist 
et al. 1996; Mayer-Popken et al. 1986), both 
in plasma and erythro cytes (Truska et al. 
1989). However, the opposite has also been 
reported (Hubermont et al. 1978; Needham 
et al. 2011; Tekin et al. 2011b), and some 
authors described inter individual variations in 
the transference of Pb from maternal blood to 
the placenta (Baghurst et al. 1991; Needham 
et al. 2011).
A positive correlation between placental 
and maternal blood Pb has been reported, 
both in ante natal controls (Baghurst et al. 
1991; Lagerkvist et al. 1996) and in specimens 
collected on the day of birth (Khera et al. 
1980; Li et al. 2000; Loiacono et al. 1992; 
Odland et al. 2001; Roels et al. 1978; Saxena 
et al. 1994; Schramel et al. 1988). Similarly, 
placental levels showed a positive correlation 
with cord blood levels (Baghurst et al. 1991; 
Loiacono et al. 1992; Needham et al. 2011; 
Odland et al. 2001; Roels et al. 1978; Saxena 
et al. 1994; Schramel et al. 1988; Truska 
et al. 1989; Tsuchiya et al. 1984), with the 
one exception (Al Saleh et al. 2011). No cor-
relation was observed between placental and 
maternal milk levels (Schramel et al. 1988).
Effects of collection, processing, or preser­
va tion of specimens. Some data indicate that 
pre treatment of the placenta, elimination 
of fluids, and freezing may modify Pb levels 
(Khera et al. 1980). Regarding placental distri-
bution of Pb, Lagerkvist et al. (1996) reported 
that, in 33% of placentas, Pb concentration 
differed by a factor of approximately 2 among 
different lobuli within the same placenta, 
and Reichrtova et al. (1998a) reported that 
Pb particu late deposits were more frequently 
found in syncytio tropho blasts than at other 
sites. In contrast, another study failed to detect 
differences among samples taken from different 
parts of the same placenta (Piasek et al. 2001). 
Several studies indicated that Pb levels were 
higher in amniotic membranes (Baghurst et al. 
1991; Fahim et al. 1976; Korpela et al. 1986).
Association between maternal charac­
teristics and exposure to possible risk fac­
tors. In a recent study, Tekin et al. (2011b) 
suggested that differences in placental Pb lev-
els could be influenced by polymorphisms 
in genes that coded for metallothionein, in a 
manner similar to that of Cd. With respect 
to other maternal factors, contradictory 
results were found regarding the association 
between placental Pb and maternal age (Khera 
et al. 1980; Li et al. 2000; Roels et al. 1978; 
Terrones-Saldivar et al. 2008; Zagrodzki et al. 
2003) and with parity (Gundacker et al. 2010; 
Roels et al. 1978; Singh et al. 2010; Terrones-
Saldivar et al. 2008). One study reported an 
association between Pb and BMI (Zagrodzki 
et al. 2003).
Of the three metals reviewed, Pb dis-
played the widest geographical variation: 
Levels in placentas from normal pregnancies 
were very high in India (Ahamed et al. 2009; 
Saxena et al. 1994; Singh et al. 2010) and 
Saudi Arabia (Al Saleh et al. 2011) and low-
est in China (Li et al. 2000; Yang et al. 1997) 
and Canada (Lafond et al. 2004). 
High placental Pb concentrations have 
been reported in studies of women resid-
ing in polluted areas (Baranowska 1995; 
Zagrodzki et al. 2003) and in the proximity 
of an e-waste recycling area, with positive cor-
relations between Pb levels and both parents’ 
length of residence in the area and the father’s 
e-waste-related work (Guo et al. 2010). Of 
the four studies that assessed placental Pb 
in the vicinity of Pb smelters (Fahim et al. 
1976; Lagerkvist et al. 1996; Loiacono et al. 
1992; Tabacova et al. 1994), only one (which 
included only pregnant non smokers) reported 
a significant increase in Pb among exposed 
women (Loiacono et al. 1992). In studies that 
examined the influence of urban pollu tion on 
placental Pb levels, some authors found no 
association (Roels et al. 1978; Truska et al. 
1989; Zagrodzki et al. 2003), whereas oth-
ers reported higher Pb levels in urban areas 
(Falcón et al. 2002; Reichrtova et al. 1998b). 
Only one study addressed and reported sea-
sonal variations (Wibberley et al. 1977). 
Among lifestyle-related habits, reports on 
smoking and placental Pb yielded inconclusive 
results: Whereas some researchers described 
a clear association with smoking (Kutlu et al. 
2006; Odland et al. 2001; Stasenko et al. 
2010), others failed to confirm these results 
(Al Saleh et al. 2011; Falcón et al. 2002; Piasek 
et al. 2001; Roels et al. 1978). There were iso-
lated reports of a negative correlation between 
placental Pb and maternal poultry and mush-
room consumption (Gundacker et al. 2010) or 
with daily coffee consumption (Al Saleh et al. 
2011), as well as a positive association with 
ingestion of tap water containing Pb concen-
trations > 50 μg/L (Hubermont et al. 1978). 
In addition, Pb levels might be related to wine 
consumption before (Osman et al. 2000) but 
not during pregnancy (Gundacker et al. 2010; 
Yang et al. 1997). Increased placental Pb levels 
were also present in long-term pottery indus-
try workers, and painters in particular (Khera 
et al. 1980).
Possible effects of Pb on the placenta or 
pregnancy. Several studies found an association 
between placental Pb levels and some gesta-
tional problems. Whereas data on pregnancies 
with early membrane ruptures were inconclu-
sive, consistently high placental Pb levels—not 
always statistically significant—were reported 
for stillbirths (Baghurst et al. 1991; Khera et al. 
1980; Wibberley et al. 1977), neo natal deaths 
(Falcón et al. 2003a; Wibberley et al. 1977), 
and malformed infants (Wibberley et al. 1977), 
as well as for women reporting previous miscar-
riages (Gundacker et al. 2010). Although some 
researchers observed high Pb levels in placentas 
from pre term deliveries (Ahamed et al. 2009; 
Baghurst et al. 1991; Fagher et al. 1993; Fahim 
et al. 1976), overall, placental Pb was not asso-
ciated with gestational age (Gundacker et al. 
2010; Guo et al. 2010; Loiacono et al. 1992; 
Roels et al. 1978) except in one study (Falcón 
et al. 2003a).
The relationship of Pb with birth weight 
also yielded contradictory results. Most studies 
observed no association (Falcón et al. 2003a; 
Guo et al. 2010; Loiacono et al. 1992; Roels 
et al. 1978; Tekin et al. 2011b), but two found 
a positive correlation between Pb levels and 
birth weight (Al Saleh et al. 2011; Gundacker 
et al. 2010). In contrast, other authors reported 
an inverse correlation (Llanos and Ronco 
2009; Stasenko et al. 2010), with higher levels 
of Pb in placentas of low-birth-weight babies 
(< 2500 g) (Llanos and Ronco 2009). In addi-
tion, pregnancies with IUGR had placental 
levels that were high but not statistically signifi-
cant (Klapec et al. 2008).
Of the studies that examined whether 
Pb-related gestational problems might be 
linked to oxidative stress measured via pla-
cental biomarkers, a positive association in 
pre term gesta tion was reported by Ahamed 
et al. (2009), but Llanos and Ronco (2009) 
observed no correlation in neo nates with 
low birth weight for gesta tional age. Finally, 
one study showed that placental Pb levels 
correlated negatively with activity of steroid 
sulfatase, an enzyme implicated in the metabo-
lism of steroids (Karp and Robertson 1977).
Discussion
In this review we provide a structured break-
down of the results of studies published from 
1976 through 2011 on Hg, Cd, and Pb levels 
in human placentas. We found that the use 
of the placenta as a biomarker of exposure to 
heavy metals is not properly developed because 
of the hetero geneity among the studies. This 
heterogeneity applies not only to the popu-
lations selected but also to the processing of 
specimens and presentation of results. 
Most of the studies reporting placental 
levels of these trace metals were conducted on 
small convenience samples of healthy preg-
nant women, and the authors did not always 
describe the inclusion/exclusion criteria they 
used. These factors limit the external validity 
of the results. Furthermore, adjusted analyses 
considering basic potential confounders, such 
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as age or smoking, were not always provided. 
Specific aspects of these studies, such as type 
of birth, must be deemed confounding factors. 
The different ways of obtaining placentas in 
C-sections and vaginal births, taken together 
with the circumstances that indicate which 
technique was used, might result in differences 
unrelated to environ mental exposures. 
The lack of universally accepted protocols 
for collecting and processing placental speci-
mens also hinders comparison of the results. 
The procedure for collection, pretreatment, 
storage, and preparation of the placenta prior 
to analysis varied among studies, although 
available data suggest that such processes may 
influence the magnitude and comparability of 
the trace metal concentrations (Khera et al. 
1980; Lagerkvist et al. 1996). Particularly 
rele vant is the representativeness of the pla-
centa specimen vis-à-vis the organ as a whole. 
In many studies, a single spot tissue speci-
men was obtained. In practice, this implies 
an assumption that trace metals are uni-
formly distributed throughout the placenta. 
Nevertheless, published data, particularly in 
the case of Cd and Pb, question this assump-
tion. To solve this problem, some authors 
have suggested homogenizing the complete 
organ or instead obtaining and then aggregat-
ing and homogenizing random speci mens of 
multiple parts of the placenta (Iyengar and 
Rapp 2001a). With regard to the methodol-
ogy used for laboratory analysis, our search 
was confined to studies undertaken in 1976 
and later, a time when fundamental analyti-
cal techniques, such as nuclear activation and 
atomic absorption spectrophotometry in par-
ticular, were being developed for the purpose 
of obtaining reliable results in the quantifica-
tion of trace metals in placental tissue (Iyengar 
and Rapp 2001b). Nevertheless, we failed to 
locate studies that compared the performance 
of the various analytical approaches specifi-
cally in placental tissue. Thus, we cannot rule 
out possible variability over time attribut-
able to the different analytical methods used 
and the fine-tuning and improvement of the 
related quality-control measures. 
Because our review was limited to studies 
published in English or Spanish, results pub-
lished in other languages are under represented. 
In addition, we were unable to retrieve the 
full text of some studies (mainly non indexed), 
even after requesting copies directly from 
the authors. A further limitation is that the 
hetero geneity of the original studies prevented 
us from providing any reliable quantitative 
summary measure. Despite the limitations of 
validity and comparability, some conclusions 
can be drawn.
Few studies reported total Hg in placen-
tas. Existing studies show a good correlation 
between Hg levels in placenta and commonly 
accepted bio markers of children’s exposure, 
such as Hg in maternal and newborn blood 
and hair. Perhaps the existence of these classic 
indicators justifies in part the limited interest 
shown in placental Hg. Although higher Hg 
levels were found in Asian countries, the lack 
of association with dietary fish intake in the 
few studies conducted on women with moder-
ate consumption might generate doubts about 
its possible utility as a biomarker of exposure 
in these settings. The role of placenta as a bar-
rier for this metal is not yet clear, and even 
though the Hg level might have some effect on 
normal functioning of the placenta, it does not 
seem to be associated with deleterious effects 
on pregnancy. 
Extracted data indicate that Cd accumu-
lates in the placenta; this may explain why 
placental levels usually correlate with mater-
nal but not cord blood levels. However, if Cd 
levels in the placenta, as well as the placenta’s 
efficacy as a barrier, are modulated by mater-
nal poly morphisms linked to metallo thionein, 
this information should be considered in 
the assessment of this biomarker in terms of 
exposure. Clarification is also needed with 
respect to the possible existence of a satu-
ration threshold above which the placenta 
becomes unable to accumulate Cd, because 
this may limit the utility of specimens in 
environ mental monitoring. The single deter-
minant most clearly associated with this metal 
is exposure to smoking during pregnancy. 
Accordingly, it is essential that studies fur-
nishing information on placental Cd levels 
give detailed information on the smoking 
habits of the women and provide separate 
estimators for non smokers. Reported results 
also suggest a possible relationship between 
Cd and IUGR or low anthropometric neo-
natal parameters, which need to be confirmed 
by additional research.
Pb was the pollutant that presented the 
clearest geographic differences in placental 
concentration. The wide range of values seen 
for this metal in the placenta suggests that the 
placenta could be a good choice for biomoni-
toring environ mental Pb exposure. Available 
studies showed that Pb crosses the placenta 
but does not accumulate. They also suggested 
an association between placental Pb levels and 
some gestational disorders, such as stillbirths; 
however, the data were contradictory and 
failed to clarify a possible relationship with 
low birth weight, IUGR, or pre maturity. 
The associations between placental metal 
levels and birth weight or gestational age could 
be biased because exposure to some pollutants 
might be related to spontaneous abortion, as 
could also be possible in women with high 
Pb levels (Wibberley et al. 1977). Prospective 
studies of maternal exposure early in pregnancy 
could clarify these issues and evaluate whether 
pregnancy-related diseases may cause metal 
accumulation in placental tissue. None of the 
reviewed studies focused on the association 
between placental levels and any long-term 
effect. This is particularly rele vant in compar-
ing the utility of placental determinations of 
Hg or Pb in terms of biomonitoring because 
associations between children’s neurological 
development and levels of these metals have 
indeed been described (Wigle et al. 2008). 
In our opinion, international biomonitor-
ing committees should propose compulsory 
requirements and quality standards for all 
research involving the use of placentas to mea-
sure exposures. Studies should be required to 
have an appropriate epidemiologic design that 
is focused on ensuring the representative ness of 
the target population. They must clearly define 
inclusion/exclusion criteria and collect data on 
maternal (socio demographic, clinical, pollutant-
related exposures) and gestational charac teristics 
(complications during pregnancy, gestational 
age, type of birth, seasonality, result of gesta-
tion, and birth weight). Tissue collection, pres-
ervation, and processing of specimens likewise 
require standardization. In biomonitoring stud-
ies, initial washing of the placenta to remove 
blood, followed by homogenization of the 
whole organ, might enable more comparable 
results to be obtained by researchers. However, 
sampling of specific parts of the placenta could 
be useful for research focused on understanding 
metal deposit in this organ, as well as the pos-
sible association between metal concentration 
and gestational problems. 
Quality assurance procedures should be 
applied to laboratory processes. Among the 
available techniques, those with low detection 
limits (e.g., graphite furnace–atomic absorption 
spectrometry, inductively coupled plasma–mass 
spectrometry) might be especially suitable for 
measuring metal levels in the general popula-
tion in low-exposure environments. Finally, 
all of this information should be adequately 
described in the study reports. We recommend 
that metal levels be reported in standardized 
units (e.g., in nanograms per gram wet weight) 
and that appropriate descriptive statistics and 
their corresponding confidence intervals be 
combined with multi variate analyses to iden-
tify real risk factors associated with high levels 
of these pollutants. 
Conclusions
Although interest in the study of heavy-
metal levels in the placenta has increased in 
recent decades, published studies are exces-
sively hetero geneous. Standardized criteria for 
placenta collection, preservation, processing, 
and analysis are therefore needed to ensure 
that comparable results can be obtained. This 
will allow clarification of the possible effects 
of these metals in pregnancy, as well as the 
incorpora tion of placental tissue into environ-
mental monitoring systems based on human 
biological samples. 
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